Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gadusol is a natural marine-derived metabolite, structurally related to mycosporine-like amino acids (MAAs), primarily found in the eggs of various fish species and some invertebrates. It functions as a potent photoprotective agent by absorbing ultraviolet B (UVB) radiation and acting as a strong antioxidant. Research indicates that gadusol can protect skin cells, such as melanocytes, from UVB-induced damage, reactive oxygen species (ROS) production, and apoptosis. Due to its natural origin and efficacy, it is being explored as a sustainable and eco-friendly alternative to synthetic UV filters in sunscreens and dermatological applications. Biosynthetic pathways for gadusol have been identified in fish, and yeast-based production methods are being developed to facilitate its commercial use.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gadusol.